Obama Administration releases new National Drug Control Strategy

President Obama released the Administration's inaugural National Drug Control Strategy, which establishes five-year goals for reducing drug use and its consequences through a balanced policy of prevention, treatment, enforcement and international cooperation.

The strategy was developed by the Office of National Drug Control Policy (ONDCP) with input from a variety of federal, state and local partners. Goals include:

  • Reduce the rate of youth drug use by 15 percent;
  • Decrease drug use among young adults by 10 percent;
  • Reduce the number of chronic drug users by 15 percent;
  • Reduce the incidence of drug-induced deaths by 15 percent; and
  • Reduce the prevalence of drugged driving by 10 percent.
The strategy also outlined three significant drug challenges the Administration will specifically focus this year: prescription drug abuse, drugged driving and preventing drug use.

New strategy elements also included a focus on making recovery possible for every American addicted to drugs through an expansion of community addiction centers and the development of new medications and evidence-based treatments for addiction, the administration stated in a release.

"This strategy calls for a balanced approach to confronting the complex challenge of drug use and its consequences," said President Obama. "By boosting community-based prevention, expanding treatment, strengthening law enforcement, and working collaboratively with our global partners, we will reduce drug use and the great damage it causes in our communities."

Around the web

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.